Eligibility criteria to cisplatin in head and neck squamous cell carcinoma: Egyptian expert opinion
Abstract Introduction The use of cisplatin in clinical practice in the management of head and neck squamous cell carcinoma (HNSCC) is limited by its toxicity and acquired resistance, which makes the decision‐making process of its prescription multifactorial. Methods An Egyptian expert panel (compris...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-01-01
|
| Series: | Health Science Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/hsr2.1037 |